Neurodevelopmental disorders and co-morbid mental health disorders Mental and Behavioural Disorders
Conditions
Interventions
This randomised controlled pilot trial will include active patients who are under the care of the South London and Maudsley Hospital Lewisham Neurodevelopmental Team (NDT) and their caregivers. Caregi
Sponsors
Guy’s and St Thomas’ Charity Health Innovation Fund
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged between 4 -18 years old with under the care of Lewisham NDT with a diagnosis of Autism Spectrum Disorder (ASD) and or Attention Deficit Hyperactivity Disorder (ADHD) 2. Have at least one SDQ present in their electronic health records
Exclusion criteria
Exclusion criteria: 1. No baseline SDQ present in their electronic health records 2. Caregiver contact information not present in the patient’s electronic health records 3. Patients and their caregivers no longer active cases within SLaM Child and Adolescent Mental Health Services 4. Caregiver does not have access to a mobile internet enabled device
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Acceptability measured by focus groups and individual (phone and face-to-face interviews) at 3 months 2. Economic benefit measured by clinician reported SDQ administration cost questionnaire, including estimated time spent administer, following-up completion and scoring SDQ in the last week to be collected at monthly intervals 3. Drop-out due to internet access measured by reasons given for participant drop out as measured by targeted caregiver face-to-face and phone interviews at 3 months | — |
Primary
| Measure | Time frame |
|---|---|
| Follow-up SDQ completion at 3 months from enrolment, as measured by a count of how many SDQ forms have been filled in across the control and intervention groups at baseline and 3 months | — |
Countries
England, United Kingdom
Outcome results
None listed